gonadotrophins could be continued for an extended period of time and more oocytes could be obtained. Clinical pregnancy 3 To whom correspondence should be addressed rates per cycle and per embryo transfer were reported to Gonadotrophin-releasing hormone agonists (GnRHa) are increase with the routine use of GnRHa for IVF (Hughes et al. , widely used in in-vitro fertilization (IVF) for the prevention 1992). However, the use of GnRHa during the follicular phase of a premature rise in luteinizing hormone (LH) concentraalso impairs corpus luteum function, introducing the need for tions. However, the administration of GnRHa during the luteal phase supplementation (Smitz et al., 1987) . Defective follicular phase may also impair subsequent luteal function function of the corpus luteum after cessation of GnRHa may due to retarded recovery of pituitary gonadotrophin secrebe caused by prolonged blockage of pituitary gonadotrophin tion. Therefore, luteal supplementation is generally applied.
release during the luteal phase (Smitz et al., 1988) . It was The present study was designed to determine whether a suggested that luteal supplementation would improve premature LH surge would still be prevented after early endometrial quality and pregnancy rates (Smitz et al., 1988) .
cessation of GnRHa during ovarian stimulation and
A meta-analysis comparing pregnancy rates with and without whether subsequent luteal phase LH production would be luteal support following ovarian stimulation with gonadotrosufficient to support progesterone synthesis by the corpus phins combined with GnRHa suggested indeed that luteal luteum. Sixty patients were randomized for three groups: (i) support was beneficial (Soliman et al., 1994) .
A long GnRHa/human menopausal gonadotrophin (HMG)
Several authors have shown extremely low endogenous protocol with luteal support by repeated human chorionic LH concentrations until 10-14 days after discontinuation of gonadotrophin (HCG) (n ⍧ 20), (ii) early follicular phase the GnRHa (Smitz et al., 1992a; Donderwinkel et al., 1993 ; cessation of GnRHa without luteal support (n ⍧ 20), and Sungurtekin and Jansen, 1995) . It may therefore be (iii) a long GnRHa protocol without luteal support (n postulated that GnRHa could be stopped earlier in the stimula-⍧ 20). Frequent ultrasound and blood sampling was tion cycle, allowing pituitary recovery to occur during the performed during the entire IVF cycle. Forty normoluteal phase providing endogenous support of the corpus ovulatory women served as controls. No premature LH luteum. Preliminary observations indeed suggest that no surges were found after early cessation of GnRHa. In this premature rises in LH and progesterone concentrations took group, some pituitary recovery occurred during the late place in patients in which GnRHa was stopped earlier luteal phase, but this did not affect corpus luteum function. (Pantos et al., 1994) . The objective of the present prospective Progesterone concentrations were shown to be dependent randomized controlled study was to assess whether early on disappearance of the pre-ovulatory bolus of HCG.
follicular phase cessation of GnRHa still avoids a premature Pregnancies occurred in all three groups. In conclusion, rise in serum LH and to study luteal phase LH and progesterone early follicular phase cessation of GnRHa is still effective concentrations without exogenous support of the corpus luteum. in the prevention of a premature rise in LH. AlthoughIntroduction patients less than 39 years of age were included in the present study. All were having regular menstrual cycles (between 25 and 32 days),
The use of a gonadotrophin-releasing hormone agonist and had no known hormonal abnormalities. Indications for IVF (GnRHa) to prevent a premature rise in serum luteinizing included tubal pathology and male factor.
Forty paid volunteers aged 20-34 years with a normal regular menstrual cycle (i.e. 26-30 days), normal body weight (body mass *Presented during the 14th Annual ESHRE Meeting, Göteborg, Sweden, 1998 index 19-24 kg/m 2 ) and no history of infertility or any endocrine 8000 pmol/l was arbitrarily chosen. This was based on our own unpublished observations. It has previously been suggested that when a patient is considered to be at particular risk of developing OHSS, it is recommended that progesterone rather than HCG should be used for luteal support . However, no absolute threshold for oestradiol could be found to predict an OHSS risk .
Hormone assays
Blood samples were centrifuged at 1000 g for 15 min and serum was frozen and stored at -20°C. Serum was assayed for follicle stimulating hormone (FSH), LH, oestradiol, and progesterone concentrations. In addition, HCG concentrations were assayed during the luteal phase. Figure 1 . Schematic representation of the three different treatment From each patient, hormone assays were performed in the same run. protocols. A routine long gonadotrophin-releasing hormone agonist LH and FSH concentrations were measured by immunofluorometric (GnRHa)/human menopausal gonadotrophin (HMG) protocol with assay (Amerlite, Orto-Clinical Diagnostic, Amersham, UK) as publuteal support (group A), early cessation of GnRHa without luteal lished previously (Schipper et al., 1998) . Oestradiol and HCG support (group B), and long use of GnRHa without luteal support concentrations were measured by Coat-A-Count radioimmunoassay (group C). The small vertical lines at the top indicate the days on (Diagnostic Products Corp. Los Angeles, CA, USA). Progesterone which blood samples were taken. HCG ϭ human chorionic gonadotrophin.
concentrations were measured by radioimmunoassay kits as described previously (de Jong et al., 1974) . Intra-and inter-assay variation was less than 3 and 6% for LH, less than 5 and 7% for FSH, less than abnormalities served as controls. Daily blood sampling and trans-11 and 15% for oestradiol, less than 6 and 7% for HCG, and less vaginal ultrasound was performed, as published previously (Schipper than 11 and 12% for progesterone. Lower limit of assay sensitivity et al., 1998).
was 0.09 IU/l for LH, 0.24 IU/l for FSH and 0.5 nmol/l for Study protocol progesterone. Cross-reaction of the LH and FSH assay with the HCG injected was Ͻ0.1%. All patients were treated with the so called long protocol. The GnRHa Decapeptyl ® (Ferring Nederland B.V., Hoofddorp, The Netherlands) Statistical analysis 0.1 mg s.c. daily injections were initiated on cycle day 1. Patients were randomized on the same day (i.e. day 1 of the treatment cycle)
Potential differences in patients' ages and oestradiol concentrations on the day of HCG were tested using the Kruskal-Wallis test. To by means of sealed envelopes for one of the three treatment groups A, B or C (20 patients each). Down-regulation was confirmed determine differences in luteal phase hormone profiles the mean area under the curve (AUC) was calculated for LH, FSH, and progesterone (reflected by serum oestradiol concentration Ͻ150 pmol/l) after 3 weeks GnRHa use, and ovarian stimulation was initiated using human during the luteal phase. P values below 0.05 were considered to indicate significant differences. Statistical analysis was performed menopausal gonadotrophin (HMG) (Humegon ® ; N.V. Organon, Oss, The Netherlands) 3 amp/day (ϭ225 IU) i.m. Ultrasound examination using commercially available software packages (GraphPad prism; Statistical Package for Social Sciences, SPSS, SPSS inc. Chicago, was performed from stimulation day 6 onwards every other day until the leading follicle reached a diameter of at least 15 mm. From that IL, USA). day onwards ultrasound examinations were performed daily. Blood samples were drawn on the first day of GnRHa, on the first day of (range 3.9-10.2), 7.2 IU/l (range 4.8-10.8), and 3.8 IU/l 2)] (P ϭ 0.02). AUC and maximum concentrations for progesterone were higher in groups B and C versus higher than 8000 pmol/l, potentially a post-randomization bias could have been introduced. For this reason patients' controls (P Ͻ 0.001). Moreover, progesterone decrease started significantly later in group A [day 10 (range 8-10 after HCG)] characteristics were also analysed, including those patients showing ovarian hyper-response. Again, no differences were versus B and C [both groups day 8 (range 6-8 after HCG)] (P ϭ 0.0005). Progesterone concentrations and mean AUC found regarding patients' age, duration of stimulation, number of follicles on the day of HCG, and number of oocytes obtained were similar for groups B and C. Progesterone serum concentration decreased more gradually in controls (due to reduced after retrieval (data not shown). It was concluded that although the drop-out rate was high, no obvious post-randomization maximum concentrations) and this decrease started between days 6 and 8 following the LH surge (i.e. 4-6 days after bias was introduced.
In group A, five patients became pregnant (defined as a ovulation). Similarly, luteal phase oestradiol concentrations in group A were significantly higher (P Ͻ 0.0001) as compared positive urinary pregnancy test 17 days after oocyte retrieval), one of them was not analysed due to an oestradiol concentration to groups B and C. In turn, oestradiol concentrations in groups B and C were higher as compared to controls (P ϭ 0.005, and above 8000 pmol/l on the day of HCG. In group B, three patients became pregnant of whom all were analysed. In P ϭ 0.002 respectively). Late luteal oestradiol changes were similar to changes in progesterone. Oestradiol serum concentragroup C, one patient became pregnant (not analysed due to high oestradiol concentrations). In the analysed patients, six tions also decreased later in group A compared to groups B and C. pregnancies were ongoing. Ongoing pregnancies (n ϭ 6) ended in the birth of four healthy singletons and two healthy twins.
HCG concentrations are shown in Figure 4 . Mean AUC for groups A, B and C were 554, 347 and 290 respectively, this The remaining pregnancy was a singleton pregnancy that ended in an early abortion. This patient was in group A.
is significantly different between groups (P ϭ 0.005). In group A, HCG was administered during the luteal phase. The LH and FSH concentrations are depicted in Figure 2 . Median LH concentration on the day of HCG were 0.6 IU/l relationship between serum HCG and progesterone concentrations during the luteal phase is described in Figure 5 , separately (range Ͻ0.09-1.5), 0.4 IU/l (range Ͻ0.09-2.5) and 0.7 IU/l (range 0.4-1.0) for groups A, B and C respectively [P ϭ 0.37 for all three groups. In pregnant patients, HCG concentrations started to rise between days 12 and 14 after HCG. not significant (NS)]. In the control group median LH concentration on the day before LH surge was 4.8 IU/l (range 1.3-10.4). No premature LH rises (defined as LH concentrations Discussion above 5 IU/l) could be observed in group B patients who stopped GnRHa earlier. The median duration between GnRHa cessation
The co-administration of GnRHa in IVF has improved overall treatment outcome (Hughes et al., 1992) . However, with the and day of HCG was 7 days (range 4-10). Extremely low LH concentration were found in the luteal phase in groups A and use of GnRHa the late luteal phase progesterone production was inadequate in women not receiving luteal support (Smitz C (most concentrations below assay sensitivity). The mean area under the curve (AUC) in group B (4.8) was significantly et al., 1988; Smith et al., 1989) . GnRHa is routinely continued until oocyte retrieval criteria are met, but pituitary suppression higher compared to groups A or C (0.4, and 0.3 respectively) (P ϭ 0.01 and 0.02 respectively) but significantly lower continues after stopping GnRHa (Sungurtekin and Jansen, 1995) . Three studies were previously conducted in which (P Ͻ 0.001) versus controls (39.5). Median FSH concentrations on the day of HCG were 6.9 IU/l (range 5.6-10.4), 6.0 IU/l GnRHa was stopped earlier (Smitz et al., 1992b ; Pantos et al., 1994; Faber et al., 1998) . However, luteal support was included during ovarian stimulation. The entire follicular and luteal phase was studied and normo-ovulatory women served as in these studies and hormonal measurements were performed on the day of HCG administration only. It was observed that controls. Follicular-phase characteristics were not different in the three different treatment groups (except for a minor pituitary down-regulation continues following cessation of GnRHa early during ovarian stimulation for IVF. Indeed, unexplained difference in oestradiol concentrations). Hence, cessation of GnRHa early in the follicular phase did not affect pituitary recovery takes an extended period of time, as was also shown following HMG ovulation induction combined with ovarian stimulation by exogenous gonadotrophins. LH or progesterone rises were not observed in any patients prior to GnRHa in polycystic ovarian syndrome patients (Donderwinkel et al., 1993) .
HCG. These results confirm previously published observations (Pantos et al., 1994) . After continuation of GnRHa until HCG, If impaired luteal progesterone production were caused by prolonged pituitary suppression after GnRHa use, this may LH concentrations were extremely low during the subsequent luteal phase both with or without luteal support. Several authors normalize if pituitary recovery took place earlier in the luteal phase. In the present prospective, randomized study, it was also found early and late luteal LH serum concentrations below 1 IU/l after conventional GnRHa use until HCG ( concentrations remain extremely low for at least 14 days after day after oocyte retrieval varied from 16 to 22 days in this group. It can be concluded that some pituitary recovery discontinuation of GnRHa (Donderwinkel et al., 1993) . This was confirmed in the present study. However, the present study occurs 16-22 days after GnRHa cessation. However, LH concentrations were still below the physiological range shows for the first time that after stopping GnRHa earlier in the follicular phase, LH concentrations in the late luteal phase (Ͻ0.09-1.9 IU/l). Compared to regular cycling controls, in all three study groups more corpora lutea were present to produce partially recover. Smitz et al. found an earlier increase in LH concentration in the day of HCG after early cessation of steroids in the luteal phase. The higher concentrations of oestradiol and progesterone itself could cause extremely low GnRHa but clearly no LH rise or progesterone rise (Smitz et al., 1992b) . In the present study, from day 8 after HCG, a LH concentrations in the luteal phase by a strong negative feedback mechanism (Gibson et al., 1991) . FSH concentrations slight increase in LH concentrations was found, but these levels did not reach concentrations as measured in regularly rose in the late luteal phase in both groups without luteal support. This rise may have been secondary to reduced cycling controls. In the patients who stopped GnRHa on stimulation day 3 the interval between cessation of GnRHa negative feedback associated with decreased progesterone concentrations. and HCG was 7-13 days. Hence, the observation period from the day of discontinuation of the GnRHa until the 12th
Progesterone production occurred in both groups without support by HCG, progesterone concentrations reached a higher maximum as compared to patients without luteal support or normal regularly cycling controls. Furthermore, the increase in progesterone concentrations lasted longer while the decrease started later. This was probably due to higher HCG concentrations in the luteal phase due to HCG supplementation. Progesterone concentrations decreased the moment that HCG levels fell below approximately 30 IU/l in all three groups. In natural cycles luteal progesterone concentrations increase to a maximum of 70 nmol/l. In all groups, concentrations substantially higher than these were found. The effects of high progesterone concentrations on implantation chances in stimulated cycles are unclear (Pellicer et al., 1996) . Since progesterone concentrations. Effects on implantation chances remain unclear. Progesterone concentrations in the control luteal support. However, distinctly lower concentrations were reached and an earlier decrease in progesterone production group were at a more steady level. It is unknown whether a sharp decrease in progesterone concentration could be detriwas noted compared to the group with luteal support. This latter observation is in agreement with previous reports (Smitz mental despite preceding supraphysiological progesterone levels. et al., 1987; Valbuena et al., 1997) . Surprisingly, no difference in progesterone production was found comparing shorter or
In conclusion, this study shows that after cessation of GnRHa earlier in the follicular phase, a premature rise in LH longer GnRHa use, despite the partial recovery of LH concentrations when GnRHa was stopped earlier. This may be or progesterone concentration is still prevented. In addition, it was found that after earlier cessation of GnRHa, luteal due to a discrepancy between bioactive and immunoassayable LH following GnRHa use (Meldrum et al., 1984) or irreversible immunoassayable LH concentrations recovered partially. However, no effect on luteal progesterone production could be luteolysis before the onset of stimulation by endogenous LH. It seems likely that during the early luteal phase the corpus observed. Progesterone production in IVF patients without luteal support was higher as compared to the natural cycle, but luteum is supported by the HCG bolus (10 000 IU) administered 35 h before oocyte retrieval. This effect lasted for lower compared to patients with luteal support. As progesterone profiles in the luteal phase were not different after earlier approximately 1 week as can be seen from the relationship between decreasing HCG concentrations and the duration of discontinuation of GnRHa compared to continuation until HCG, it is concluded that endogenous support of corpus luteum progesterone production ( Figure 5 ). In patients receiving luteal
